Oscar Health, Inc.
For the period ended Sep 30, 2026. Filed Nov 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 5, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
(a)None.
(b) None.
(c) On August 18, 2026, R. Scott Blackley, the Company’s Chief Financial Officer, entered into a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c). Mr. Blackley's plan provides for the exercise of vested stock options and the associated sale of up to 500,000 shares of Class A common stock, and the additional sale of up to 500,000 shares of Class A common stock, through August 18, 2027. The plan terminates on the earlier of the date all the shares under the plan are sold and August 18, 2027. No trades will commence under the plan until after the expiration of the applicable cooling off period on November 16, 2026.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.